Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tymlos
Tymlos
Radius falters after a PhIII osteoporosis fail and a breast cancer disappointment, sending shares plummeting
Endpoints
Thu, 12/9/21 - 10:56 am
Radius Health
clinical trials
osteoporosis
breast cancer
Tymlos
Radius Health Initiates Phase III Trial of Osteoporosis Injection Drug for Males
CP Wire
Mon, 04/2/18 - 03:08 pm
Radius Health
osteoporosis
men's health
Tymlos
clinical trials
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
RAPS.org
Fri, 03/23/18 - 10:10 am
EMA
Europe
CHMP
FDA
Bevyxxa
Portola Pharmaceuticals
Dexxience
Tymlos
Radius Health
Eladynos
Payer coverage boosts Radius' Tymlos
BioPharma Dive
Fri, 08/4/17 - 11:40 am
Radius Health
Tymlos
PBMs
Express Scripts
osteoporosis
Radius' Tymlos gets another big break as Express Scripts boots Lilly's Forteo
Fierce Pharma
Tue, 08/1/17 - 11:49 am
Radius Health
Tymlos
Express Scripts
PBMs
formulary
Eli Lilly
Forteo
osteoporosis
An Endocrinologist Explains Her View Of Tymlos And The Osteoporosis Landscape
Seeking Alpha
Mon, 07/24/17 - 10:44 am
Amgen
Radius Health
osteoporosis
Tymlos
romosozumab
FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO
Endpoints
Mon, 07/17/17 - 09:15 am
FDA
Amgen
osteoporosis
romosozumab
UCB Pharma
Radius Health
Tymlos
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Fierce Pharma
Mon, 05/22/17 - 09:45 am
Amgen
romosozumab
Radius Health
UCB Pharma
Tymlos
osteoporosis
With Amgen hot on its heels, Radius races to get a jump on osteoporosis drug rivalry
Endpoints
Mon, 05/1/17 - 10:57 am
Amgen
Radius Health
osteoporosis
Tymlos
romosozumab
FDA approves Radius Health's osteoporosis drug Tymlos
Yahoo/Reuters
Sat, 04/29/17 - 10:10 am
FDA
Radius Health
osteoporosis
Tymlos